AAAAI & ACAAI GUIDELINES Bundle (free trial)

Primary Immunodeficiency

AAAAI & ACAAI GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/802140

Contents of this Issue

Navigation

Page 6 of 59

7 Diagnosis General Considerations Î SS 1. It is critical to maintain a high index of suspicion for PIDDs in patients presenting with recurrent infections, autoimmune disease, malignancy, and combinations of these conditions (D). Î SS 2. Other conditions that can increase susceptibility to infection should be sought in patients with suspected PIDDs. (D) Î SS 3. It is important to confirm the precise focus of infection and organism when possible in any patient with known or suspected PIDDs. (F) Î SS 4. A focused family history (eg, recurrent infections, absence of infections in siblings, early childhood deaths, and diagnosed PIDDs) should be obtained when the differential diagnosis includes a PIDD. (D) Î SS 5. A stepwise approach is recommended to evaluate suspected PIDDs. (D) Î SS 6. Evaluation of specific immune responses is essential for diagnosis of PIDDs. (C) Î SS 7. PIDDs should be defined at the molecular genetic level if management can be affected. (F) Î SS 8. The possibility of an X-linked PIDD should be considered, even in female patients, when other possibilities have been ruled out. (D) Î SS 9. Carrier status should be determined for all potentially affected relatives of patients with severe PIDDs. (D)

Articles in this issue

Archives of this issue

view archives of AAAAI & ACAAI GUIDELINES Bundle (free trial) - Primary Immunodeficiency